α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model

Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications

E. J. Corey, Raman K. Bakshi, Saizo Shibata · Journal of the American Chemical Society · 1987 · 1.4K citations

Natural Sciences, Chemistry, Biocatalysis +10

A-317491, a novel potent and selective non-nucleotide antagonist of P2X ₃ and P2X _2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 466 citations

Medicine, Neurobiology, Pharmacology +17

A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

Prisca Honoré, Carol T. Wismer, Joe Mikusa et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 255 citations

Medicine, Neuroscience, Pharmacology +17

Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain:  Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt et al. · Journal of Medicinal Chemistry · 2005 · 163 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel and Selective Transient Receptor Potential Type V1 Receptor Antagonist, Blocks Channel Activation by Vanilloids, Heat, and Acid

Rachid El Kouhen, Carol S. Surowy, Bruce R. Bianchi et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 111 citations

Medicine, Medicinal Chemistry, Pharmacology +17